Sleep medicine
-
Multicenter Study Clinical Trial
A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome.
To assess the long-term safety and efficacy of ropinirole in the treatment of patients with restless legs syndrome (RLS) over 52 weeks. ⋯ Ropinirole was well tolerated and therapeutic efficacy was maintained over 52 weeks in patients with RLS.